Iodine isotope (131I) therapy for toxic nodular goitre: treatment efficacy parameters

Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters.

BACKGROUND When planning radioactive iodine therapy, it frequently happens, both in Poland and world-wide, that inadequate attention is paid to such easily measurable parameter sas: 1) the serum concentration of thyrotropin (TSH) before administering radioiodine, which is a key factor for extranodular(non-autonomous) iodine uptake of the thyroid gland, 2) thyroid gland iodine uptake, and 3) the...

Symptoms of non-toxic nodular goitre.

IN 1932, Cecil Joll, in his book "Diseases of the Thyroid Gland" emphasised that "although respiratory symptoms due to tracheal compression and alteration of voice were common", dysphagia was a "decidedly rare feature of simple goitre". Since then there has been little documentation on the subject. The following is an account of the symptoms found in a series of patients undergoing surgery for ...

The influence of non-radioactive iodine (127I) on the outcome of radioiodine (131I) therapy in patients with Graves' disease and toxic nodular goitre.

BACKGROUND The aim of the study was to achieve an effective target dose in the thyroid by increasing the effective half-life (Teff) of (131)I by use of iodide ((127)I) two days after (131)I therapy in patients with hyperthyroidism with low Teff. MATERIAL AND METHODS The study was carried out in two groups. Group A - 41 patients, and Group B - 14 patients, all the patients were with hyperthyro...

Non-toxic nodular goitre and thyroid nodules

The present opinions on the therapy with L-thyroxine (L-T4) of non-toxic multinodular, as well as of non-toxic thyroid nodules are rather divergent. This treatment is based on the suppression of TSH secretion from the pitu-

Treatment of Goitre with Iodine